Truist raised the firm’s price target on Sila Realty Trust (SILA) to $28 from $27 and keeps a Buy rating on the shares. The company appears well positioned amid macroeconomic uncertainty as a triple-net healthcare REIT with 3.3-times net debt to EBITDA, no debt maturities until 2027, 96% occupancy, and only 2% of leases expiring in 2025, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILA: